Successful Treatment of Symptomatic Epilepsy with Oral Valproic Acid and Levetiracetam in a Patient with Short-bowel Syndrome

Kurishima, A; Hayashi, M; Shimozato, R; Isozaki, R; Shioda, T; Iijima, A

Kurishima, A (通讯作者),Japan Community Hlth Care Org Tokyo Shinjuku Med, Dept Pharm, Tokyo, Japan.

INTERNAL MEDICINE, 2022; 61 (9): 1457

Abstract

Valproic acid (VPA) and levetiracetam (LEV) are used in epilepsy treatment. However, their use to treat short-bowel syndrome has not been reported. We......

Full Text Link